Literature DB >> 16041617

Reduced 123I-BMIPP uptake implies decreased myocardial flow reserve in patients with chronic stable angina.

Hiroyuki Kageyama1, Koichi Morita, Chietsugu Katoh, Takahiro Tsukamoto, Kazuyuki Noriyasu, Megumi Mabuchi, Masanao Naya, Yuko Kawai, Nagara Tamaki.   

Abstract

PURPOSE: Long-chain fatty acid (LCFA) is the main energy source for normal myocardium at rest, but in ischemic myocardium, the main energy substrate shifts from LCFA to glucose. 123I-BMIPP is a radiolabeled LCFA analog. In chronic stable angina without previous infarction, we suppose that reduced 123I-BMIPP uptake is related to the substrate shift in myocardium with decreased myocardial flow reserve (MFR). The purpose of this study was to relate 123I-BMIPP uptake to rest myocardial blood flow (MBF), hyperemic MBF, and MFR assessed with 15O-water positron emission tomography (PET).
METHODS: We enrolled 21 patients with chronic stable angina without previous infarction, all of whom underwent 123I-BMIPP single-photon emission computed tomography (SPECT) and 15O-water PET. The left ventricle was divided into 13 segments. In each segment, rest MBF and hyperemic MBF were measured by PET. 123I-BMIPP uptake was evaluated as follows: score 0=normal, 1=slightly decreased uptake, 2=moderately decreased uptake, 3=severely decreased uptake, and 4=complete defect. 123I-BMIPP uptake was compared with rest MBF, hyperemic MBF, and MFR.
RESULTS: The numbers of segments with 123I-BMIPP scores 0, 1, 2, 3, and 4 were 178, 40, 25, 24, and 0, respectively. The rest MBFs for scores 0, 1, 2, and 3 were 0.93+/-0.25, 0.86+/-0.21, 0.97+/-0.30, and 0.99+/-0.37 ml/min/g, respectively. The hyperemic MBFs for scores 0, 1, 2, and 3 were 2.76+/-1.29, 1.84+/-0.74, 1.37+/-0.39, and 1.08+/-0.40 ml/min/g, respectively. The MFRs for scores 0, 1, 2, and 3 were 3.01+/-1.38, 2.20+/-0.95, 1.44+/-0.22, and 1.10+/-0.26, respectively. As 123I-BMIPP uptake declined, hyperemic MBF and MFR decreased.
CONCLUSION: In chronic stable angina without previous infarction, reduced 123I-BMIPP uptake implies decreased MFR.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16041617     DOI: 10.1007/s00259-005-1863-3

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  49 in total

1.  Quantification of 99Tcm-sestamibi and 123I-BMIPP uptake for predicting functional outcome in chronically ischaemic dysfunctional myocardium.

Authors:  A S Hambye; A Vervaet; A Dobbeleir
Journal:  Nucl Med Commun       Date:  1999-08       Impact factor: 1.690

2.  Significance of reduced uptake of iodinated fatty acid analogue for the evaluation of patients with acute chest pain.

Authors:  Y Kawai; E Tsukamoto; Y Nozaki; K Morita; M Sakurai; N Tamaki
Journal:  J Am Coll Cardiol       Date:  2001-12       Impact factor: 24.094

3.  Hypoxia inhibits the peroxisome proliferator-activated receptor alpha/retinoid X receptor gene regulatory pathway in cardiac myocytes: a mechanism for O2-dependent modulation of mitochondrial fatty acid oxidation.

Authors:  J M Huss; F H Levy; D P Kelly
Journal:  J Biol Chem       Date:  2001-05-22       Impact factor: 5.157

4.  Pharmacokinetics and metabolism of 123I-BMIPP fatty acid analog in healthy and CD36-deficient subjects.

Authors:  T Yoshizumi; S Nozaki; K Fukuchi; K Yamasaki; T Fukuchi; T Maruyama; Y Tomiyama; S Yamashita; T Nishimura; Y Matsuzawa
Journal:  J Nucl Med       Date:  2000-07       Impact factor: 10.057

5.  Reduction of coronary flow reserve in areas with and without ischemia on stress perfusion imaging in patients with coronary artery disease: a study using oxygen 15-labeled water PET.

Authors:  Keiichiro Yoshinaga; Chietsugu Katoh; Kazuyuki Noriyasu; Yasuyoshi Iwado; Hideto Furuyama; Yoshinori Ito; Yuji Kuge; Tetsuro Kohya; Akira Kitabatake; Nagara Tamaki
Journal:  J Nucl Cardiol       Date:  2003 May-Jun       Impact factor: 5.952

6.  Enhanced myocardial glucose use in patients with a deficiency in long-chain fatty acid transport (CD36 deficiency).

Authors:  K Fukuchi; S Nozaki; T Yoshizumi; S Hasegawa; T Uehara; T Nakagawa; T Kobayashi; Y Tomiyama; S Yamashita; Y Matsuzawa; T Nishimura
Journal:  J Nucl Med       Date:  1999-02       Impact factor: 10.057

7.  High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5'-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase.

Authors:  N Kudo; A J Barr; R L Barr; S Desai; G D Lopaschuk
Journal:  J Biol Chem       Date:  1995-07-21       Impact factor: 5.157

8.  Increased uptake of 18F-fluorodeoxyglucose in postischemic myocardium of patients with exercise-induced angina.

Authors:  P Camici; L I Araujo; T Spinks; A A Lammertsma; J C Kaski; M J Shea; A P Selwyn; T Jones; A Maseri
Journal:  Circulation       Date:  1986-07       Impact factor: 29.690

9.  Early impairment of coronary flow reserve in young men with borderline hypertension.

Authors:  H Laine; O T Raitakari; H Niinikoski; O P Pitkänen; H Iida; J Viikari; P Nuutila; J Knuuti
Journal:  J Am Coll Cardiol       Date:  1998-07       Impact factor: 24.094

10.  Myocardial perfusion-contraction matching. Implications for coronary heart disease and hibernation.

Authors:  J Ross
Journal:  Circulation       Date:  1991-03       Impact factor: 29.690

View more
  7 in total

Review 1.  Diagnostic and prognostic value of BMIPP imaging.

Authors:  Taishiro Chikamori; Akira Yamashina; Satoshi Hida; Tsunehiko Nishimura
Journal:  J Nucl Cardiol       Date:  2007-01       Impact factor: 5.952

Review 2.  The Japanese experience with metabolic imaging in the clinical setting.

Authors:  Nagara Tamaki; Koichi Morita; Yuko Kawai
Journal:  J Nucl Cardiol       Date:  2007 May-Jun       Impact factor: 5.952

3.  Nuclear cardiology in the literature.

Authors:  Kenneth A Brown
Journal:  J Nucl Cardiol       Date:  2006-07       Impact factor: 5.952

Review 4.  Imaging of myocardial fatty acid oxidation.

Authors:  Kieren J Mather; Timothy R DeGrado
Journal:  Biochim Biophys Acta       Date:  2016-02-27

Review 5.  Ischaemic memory imaging using metabolic radiopharmaceuticals: overview of clinical settings and ongoing investigations.

Authors:  Keiichiro Yoshinaga; Masanao Naya; Tohru Shiga; Eriko Suzuki; Nagara Tamaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-11-12       Impact factor: 9.236

Review 6.  Metabolic imaging using SPECT.

Authors:  Junichi Taki; Ichiro Matsunari
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-06       Impact factor: 9.236

7.  Myocardial ischaemia and metabolic memory.

Authors:  Paolo G Camici
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-01       Impact factor: 9.236

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.